Singh, Gagandeep https://orcid.org/0000-0003-3260-2631
García-Bernalt Diego, Juan https://orcid.org/0000-0001-6947-6806
Warang, Prajakta https://orcid.org/0000-0002-5571-8277
Park, Seok-Chan
Chang, Lauren A. https://orcid.org/0000-0002-3287-3987
Noureddine, Moataz
Laghlali, Gabriel
Bykov, Yonina
Prellberg, Matthew https://orcid.org/0000-0001-9608-789X
Yan, Vivian https://orcid.org/0009-0009-0397-623X
Singh, Sarabjot
Pache, Lars https://orcid.org/0000-0002-4193-1042
Cuadrado-Castano, Sara https://orcid.org/0000-0002-9400-746X
Webb, Brett
García-Sastre, Adolfo https://orcid.org/0000-0002-6551-1827
Schotsaert, Michael https://orcid.org/0000-0003-3156-3132
Article History
Received: 19 November 2023
Accepted: 6 November 2024
First Online: 23 November 2024
Competing interests
: The M.S. laboratory has received unrelated funding support in sponsored research agreements from Phio Pharmaceuticals, 7Hills Pharma, ArgenX BV and Moderna. The A.G.-S. laboratory has received research support from GSK, Pfizer, Senhwa Biosciences, Kenall Manufacturing, Blade Therapeutics, Avimex, Johnson & Johnson, Dynavax, 7Hills Pharma, Pharmamar, ImmunityBio, Accurius, Nanocomposix, Hexamer, N-fold LLC, Model Medicines, Atea Pharma, Applied Biological Laboratories and Merck, outside of the reported work. A.G.-S. has consulting agreements for the following companies involving cash and/or stock: Castlevax, Amovir, Vivaldi Biosciences, Contrafect, 7Hills Pharma, Avimex, Pagoda, Accurius, Esperovax, Farmak, Applied Biological Laboratories, Pharmamar, CureLab Oncology, CureLab Veterinary, Synairgen, Paratus and Pfizer, outside of the reported work. A.G.-S. has been an invited speaker in meeting events organized by Seqirus, Janssen, Abbott and Astrazeneca. A.G.-S. is inventor on patents and patent applications on the use of antivirals and vaccines for the treatment and prevention of virus infections and cancer, owned by the Icahn School of Medicine at Mount Sinai, New York. The remaining authors declare no competing interests.